We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
-15.67%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$4.98B
AUM Growth
-$1.04B
(-17%)
Cap. Flow
+$50.1M
Cap. Flow
% of AUM
1.01%
Top 10 Holdings %
Top 10 Hldgs %
30.66%
Holding
1,260
New
93
Increased
866
Reduced
230
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$40.1M |
| 2 |
Procter & Gamble
PG
|
+$19.2M |
| 3 |
Merck
MRK
|
+$12.2M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$10.3M |
| 5 |
IBM
IBM
|
+$9.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$37.9M |
| 2 |
Apple
AAPL
|
+$19.7M |
| 3 |
Microsoft
MSFT
|
+$14.9M |
| 4 |
Home Depot
HD
|
+$14.7M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.34% |
| 2 | Healthcare | 13.95% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Financials | 10.87% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
1076
DELISTED
Apellis Pharmaceuticals
APLS
| $221K | ﹤0.01% |
+4,885
| New | +$223K |
|
1077
Houlihan Lokey
HLI
$9.14B
| $219K | ﹤0.01% |
2,773
+343
| +14% | +$28.7K |
|
1078
Worthington Enterprises
WOR
$2.83B
| $219K | ﹤0.01% |
8,056
+240
| +3% | +$6.95K |
|
1079
New Fortress Energy
NFE
$87.1M
| $217K | ﹤0.01% |
+5,491
| New | +$237K |
|
1080
The Ensign Group
ENSG
$10.1B
| $216K | ﹤0.01% |
2,938
+422
| +17% | +$33.7K |
|
1081
Doximity
DOCS
$4.56B
| $213K | ﹤0.01% |
+6,107
| New | +$240K |
|
|
OLPX
1082
DELISTED
Olaplex Holdings
OLPX
| $212K | ﹤0.01% |
+15,053
| New | +$223K |
|
|
CIVI
1083
DELISTED
Civitas Resources
CIVI
| $211K | ﹤0.01% |
+4,030
| New | +$263K |
|
1084
Nutanix
NTNX
$18.9B
| $210K | ﹤0.01% |
14,355
-9,358
| -39% | -$195K |
|
1085
Intellia Therapeutics
NTLA
$1.84B
| $209K | ﹤0.01% |
4,040
+732
| +22% | +$37.2K |
|
1086
Kyndryl
KD
$2.89B
| $208K | ﹤0.01% |
21,257
+1,115
| +6% | +$13K |
|
1087
Phillips Edison & Co
PECO
$5.05B
| $207K | ﹤0.01% |
+6,189
| New | +$210K |
|
1088
Shift4
FOUR
$3.47B
| $206K | ﹤0.01% |
6,234
+1,374
| +28% | +$64.9K |
|
1089
Ally Financial
ALLY
$13B
| $205K | ﹤0.01% |
+6,117
| New | +$244K |
|
|
GAP
1090
The Gap Inc
GAP
$7.48B
| $205K | ﹤0.01% |
24,879
-2,339
| -9% | -$27.1K |
|
1091
American Homes 4 Rent
AMH
$12B
| $204K | ﹤0.01% |
+5,748
| New | +$218K |
|
1092
Axalta
AXTA
$7.85B
| $204K | ﹤0.01% |
+9,233
| New | +$235K |
|
1093
BILL Holdings
BILL
$4.87B
| $203K | ﹤0.01% |
1,845
-8,853
| -83% | -$1.29M |
|
|
SPWR
1094
DELISTED
SunPower Corporation Common Stock
SPWR
| $203K | ﹤0.01% |
12,841
+646
| +5% | +$11.6K |
|
1095
Certara
CERT
$1.28B
| $201K | ﹤0.01% |
+9,347
| New | +$185K |
|
1096
Independent Bank
INDB
$3.9B
| $201K | ﹤0.01% |
+2,535
| New | +$201K |
|
|
LTHM
1097
DELISTED
Livent Corporation
LTHM
| $200K | ﹤0.01% |
8,817
+1,121
| +15% | +$28.8K |
|
1098
Radian Group
RDN
$4.83B
| $198K | ﹤0.01% |
10,088
+841
| +9% | +$17.7K |
|
1099
Marqeta
MQ
$1.69B
| $189K | ﹤0.01% |
+5,833
| New | +$229K |
|
1100
Under Armour Class C
UA
$2.13B
| $189K | ﹤0.01% |
24,965
+7,052
| +39% | +$79.3K |
|
Similar funds
PCM
LPC
CAM
MFG
PAM
BS
BBVA
NMO
Xponance's Q2 2022 Portfolio in Review
As of Q2 2022, Xponance held 1,260 positions worth $4.98B, down 17% from $6.01B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Xponance's Q2 2022 filing shows 93 new, 866 increased, 230 reduced and 68 closed positions. Its largest new stake was Warner Bros: 370,598 shares worth $4.97M. The largest sale was Meta Platforms (Facebook), an estimated $37.9M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Xponance's largest Q2 2022 buy was Warner Bros: 370,598 shares worth $4.97M.
- Xponance added most to UnitedHealth in Q2 2022, an estimated $40.1M increase.
- Xponance's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $37.9M.
- Xponance fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $2.36M.
- Xponance's ten largest holdings make up 31% of its $4.98B portfolio in Q2 2022.
- Xponance opened 93 new positions and closed 68 in Q2 2022.
- Xponance's portfolio value fell 17% quarter-over-quarter to $4.98B.
Based on Xponance's 13F filing for Q2 2022, filed 2 Aug 2022.